United States Biotechnology & Medical Research

Entrada Therapeutics Inc (TRDA)

Track

Entrada Therapeutics Inc. has seen significant insider selling activity over the past 90 days, with a net sell value exceeding $3.3 million. While executives and affiliated stockholders have executed multiple planned and proposed sales, there was a single buy transaction of $29,316 in May. The stock has declined 57.1% over the last quarter.
Ticker: TRDA Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Entrada Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 10 Aug 2026
Value US$4,189,100.51 | Price 180.00 | Shares 66,304 (+35.3%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-10 2026-08-10 S Sale
4.0
PARMAR KUSH
Non-Executive Director
66,304 +35.3%
180.00
US$4,189,101 		66,304 +35.3% 180.00 US$4,189,101
2026-08-10 2026-08-07 S Sale
4.0
PARMAR KUSH
Non-Executive Director
87,371 -4.6%
416.94
US$2,848,478 		87,371 -4.6% 416.94 US$2,848,478
2026-08-10 2026-08-07 S Sale
3.5
5AM Ventures V, L.P.
Large shareholder
77,858 +18.9%
80.14
US$1,617,172 		77,858 +18.9% 80.14 US$1,617,172
2026-08-10 2026-08-06 S Sale
4.0
PARMAR KUSH
Non-Executive Director
1,000 -0.4%
7.00
US$100,000 		1,000 -0.4% 7.00 US$100,000
2026-08-10 2026-08-06 S Sale
3.5
5AM Ventures V, L.P.
Large shareholder
1,000 -0.4%
7.00
US$100,000 		1,000 -0.4% 7.00 US$100,000
2026-08-03 2026-07-31 S Sale
3.5
5AM Ventures V, L.P.
Large shareholder
1,000 -0.1%
6.85
US$100,000 		1,000 -0.1% 6.85 US$100,000
2026-08-03 2026-07-31 S Sale
4.0
PARMAR KUSH
Non-Executive Director Large shareholder
1,000 -0.1%
6.85
US$100,000 		1,000 -0.1% 6.85 US$100,000
2026-08-10 2026-07-30 PrS Proposed sale
3.5
5AM Ventures V, L.P.

Affiliated stockholder

Large shareholder
1,000
6.55
US$100,000 		1,000 6.55 US$100,000
2026-08-10 2026-07-30 PrS Proposed sale
3.5
5AM Ventures V, L.P.

Affiliated stockholder

Large shareholder
1,000
6.55
US$100,000 		1,000 6.55 US$100,000
2026-08-03 2026-07-30 S Sale
3.5
5AM Ventures V, L.P.
Large shareholder
1,000 -3.9%
6.93
US$100,000 		1,000 -3.9% 6.93 US$100,000
2026-08-03 2026-07-30 S Sale
4.0
PARMAR KUSH
Non-Executive Director Large shareholder
1,000 -3.9%
6.93
US$100,000 		1,000 -3.9% 6.93 US$100,000
2026-07-30 2026-07-30 PrS Proposed sale
3.5
5AM Ventures V, L.P.

Affiliated stockholder

Large shareholder
1,000
6.55
US$100,000 		1,000 6.55 US$100,000
2026-05-21 2026-05-20 B Purchase
3.5
Zeiher Bernhardt G
Non-Executive Director
5,000 +inf%
5.86
US$29,316 		5,000 +inf% 5.86 US$29,316
2026-05-04 2026-05-04 PlS Planned sale
Sethuraman Natarajan

President, Research & Develop.

Officer
25,907 -10.7%
15.39
US$398,810 		25,907 -10.7% 15.39 US$398,810
2026-05-04 2026-05-04 PlS Planned sale
Dowden Nathan J

President & COO

Officer
15,000 -7.0%
15.33
US$229,953 		15,000 -7.0% 15.33 US$229,953
2026-05-04 2026-05-04 PrS Proposed sale
NATHAN DOWDEN

Officer

Officer
15,000
14.50
US$217,500 		15,000 14.50 US$217,500
2026-05-04 2026-05-04 PrS Proposed sale
NATARAJAN SETHURAMAN

Officer

Officer
25,907
14.50
US$375,652 		25,907 14.50 US$375,652
2026-04-02 2026-04-01 PlS Planned sale
3.4
WENTWORTH KORY JAMES

Chief Financial Officer

Officer
2,500 -2.1%
12.95
US$32,375 		2,500 -2.1% 12.95 US$32,375
2026-04-01 2026-04-01 PrS Proposed sale
3.4
KORY WENTWORTH

Officer

Officer
2,500
12.62
US$31,550 		2,500 12.62 US$31,550
2026-03-11 2026-03-10 PlS Planned sale
Dowden Nathan J

President & COO

Officer
11,894 -5.7%
13.05
US$155,188 		11,894 -5.7% 13.05 US$155,188
2026-03-11 2026-03-10 PlS Planned sale
3.4
WENTWORTH KORY JAMES

Chief Financial Officer

Officer
11,388 -8.6%
13.02
US$148,216 		11,388 -8.6% 13.02 US$148,216
2026-03-11 2026-03-09 PlS Planned sale
Dowden Nathan J

President & COO

Officer
3,116 -1.5%
13.02
US$40,583 		3,116 -1.5% 13.02 US$40,583
2026-03-11 2026-03-09 PlS Planned sale
3.4
WENTWORTH KORY JAMES

Chief Financial Officer

Officer
5,089 -3.7%
13.00
US$66,163 		5,089 -3.7% 13.00 US$66,163
2026-03-09 2026-03-09 PrS Proposed sale
3.4
KORY WENTWORTH

Officer

Officer
16,477
12.58
US$207,281 		16,477 12.58 US$207,281
2026-03-09 2026-03-09 PrS Proposed sale
NATHAN DOWDEN

Officer

Officer
15,010
12.58
US$188,826 		15,010 12.58 US$188,826
2026-03-06 2026-03-04 PlS Planned sale
3.4
WENTWORTH KORY JAMES

Chief Financial Officer

Officer
7,988 -5.5%
12.25
US$97,892 		7,988 -5.5% 12.25 US$97,892
2026-03-04 2026-03-04 PrS Proposed sale
3.4
KORY WENTWORTH

Officer

Officer
7,988
11.85
US$94,658 		7,988 11.85 US$94,658
2025-11-24 2025-11-21 PlS Planned sale
3.4
WENTWORTH KORY JAMES

Chief Financial Officer

Officer
8,910 -7.5%
9.98
US$88,932 		8,910 -7.5% 9.98 US$88,932
2025-11-21 2025-11-21 PrS Proposed sale
3.4
KORY WENTWORTH

Officer

Officer
8,910
9.17
US$81,705 		8,910 9.17 US$81,705
2025-11-24 2025-11-20 B Purchase
3.3
BAKER BROS. ADVISORS LP
Large shareholder
13,082 +0.3%
9.07
US$118,690 		13,082 +0.3% 9.07 US$118,690
2025-11-24 2025-11-20 B Purchase
3.3
BAKER BROS. ADVISORS LP
Large shareholder
1,186 +0.3%
9.07
US$10,760 		1,186 +0.3% 9.07 US$10,760
2025-11-24 2025-11-20 B Purchase
3.3
BAKER BROS. ADVISORS LP
Large shareholder
13,386 +0.3%
9.07
US$121,395 		13,386 +0.3% 9.07 US$121,395
2025-11-24 2025-11-20 B Purchase
3.3
BAKER BROS. ADVISORS LP
Large shareholder
1,213 +0.3%
9.07
US$11,000 		1,213 +0.3% 9.07 US$11,000
2025-11-18 2025-11-14 S Sale
3.5
5AM Ventures V, L.P.
Large shareholder
200,000 -6.3%
8.80
US$1,760,000 		200,000 -6.3% 8.80 US$1,760,000
2025-11-18 2025-11-14 S Sale
4.0
PARMAR KUSH
Non-Executive Director Large shareholder
200,000 -6.3%
8.80
US$1,760,000 		200,000 -6.3% 8.80 US$1,760,000
2025-11-14 2025-11-14 PrS Proposed sale
3.5
5AM Ventures V, L.P.

Affiliated Stockholder

Large shareholder
200,000
8.80
US$1,760,664 		200,000 8.80 US$1,760,664
2025-11-12 2025-11-12 B Purchase
3.3
BAKER BROS. ADVISORS LP
Large shareholder
11,494 +0.2%
7.95
US$91,431 		11,494 +0.2% 7.95 US$91,431
2025-11-12 2025-11-12 B Purchase
3.3
BAKER BROS. ADVISORS LP
Large shareholder
1,040 +0.3%
7.95
US$8,273 		1,040 +0.3% 7.95 US$8,273
2025-11-12 2025-11-12 B Purchase
3.3
BAKER BROS. ADVISORS LP
Large shareholder
80,881 +1.8%
7.73
US$625,331 		80,881 +1.8% 7.73 US$625,331
2025-11-12 2025-11-12 B Purchase
3.3
BAKER BROS. ADVISORS LP
Large shareholder
7,321 +2.0%
7.73
US$56,602 		7,321 +2.0% 7.73 US$56,602
2025-11-12 2025-11-11 B Purchase
3.3
BAKER BROS. ADVISORS LP
Large shareholder
30,879 +0.7%
7.54
US$232,812 		30,879 +0.7% 7.54 US$232,812
2025-11-12 2025-11-11 B Purchase
3.3
BAKER BROS. ADVISORS LP
Large shareholder
2,795 +0.8%
7.54
US$21,073 		2,795 +0.8% 7.54 US$21,073
2025-11-12 2025-11-11 B Purchase
3.3
BAKER BROS. ADVISORS LP
Large shareholder
11,701 +0.3%
7.39
US$86,481 		11,701 +0.3% 7.39 US$86,481
2025-11-12 2025-11-11 B Purchase
3.3
BAKER BROS. ADVISORS LP
Large shareholder
1,059 +0.3%
7.39
US$7,827 		1,059 +0.3% 7.39 US$7,827
2025-11-12 2025-11-10 B Purchase
3.3
BAKER BROS. ADVISORS LP
Large shareholder
2,947 +0.1%
7.22
US$21,290 		2,947 +0.1% 7.22 US$21,290
2025-11-12 2025-11-10 B Purchase
3.3
BAKER BROS. ADVISORS LP
Large shareholder
267 +0.1%
7.22
US$1,929 		267 +0.1% 7.22 US$1,929
2025-11-12 2025-11-10 B Purchase
3.3
BAKER BROS. ADVISORS LP
Large shareholder
25,364 +0.6%
7.21
US$182,973 		25,364 +0.6% 7.21 US$182,973
2025-11-12 2025-11-10 B Purchase
3.3
BAKER BROS. ADVISORS LP
Large shareholder
2,296 +0.6%
7.21
US$16,563 		2,296 +0.6% 7.21 US$16,563
2025-07-11 2025-07-09 S Sale
3.5
5AM Ventures V, L.P.
Large shareholder
6,935 -0.6%
7.50
US$52,026 		6,935 -0.6% 7.50 US$52,026
2025-07-11 2025-07-09 S Sale
3.5
5AM Ventures V, L.P.
Large shareholder
20,065 -0.6%
7.50
US$150,528 		20,065 -0.6% 7.50 US$150,528
2025-07-11 2025-07-09 S Sale
4.0
PARMAR KUSH
Non-Executive Director Large shareholder
6,935 -0.6%
7.50
US$52,026 		6,935 -0.6% 7.50 US$52,026
2025-07-11 2025-07-09 S Sale
4.0
PARMAR KUSH
Non-Executive Director Large shareholder
20,065 -0.6%
7.50
US$150,528 		20,065 -0.6% 7.50 US$150,528
2025-07-09 2025-07-09 PrS Proposed sale
3.6
5AM Opportunities I, L.P.

Director

Non-Executive Director
6,935
7.50
US$52,025 		6,935 7.50 US$52,025
2025-07-09 2025-07-09 PrS Proposed sale
3.5
5AM Ventures V, L.P.

Director

Non-Executive Director
20,065
7.50
US$150,528 		20,065 7.50 US$150,528
2025-07-01 2025-07-01 PrS Proposed sale
3.5
5AM Ventures V, L.P.

Director

Non-Executive Director
18,578
7.12
US$132,324 		18,578 7.12 US$132,324
2025-07-01 2025-07-01 PrS Proposed sale
3.6
5AM Opportunities I, L.P.

Director

Non-Executive Director
6,422
7.12
US$45,737 		6,422 7.12 US$45,737
2025-07-01 2025-07-01 S Sale
4.0
PARMAR KUSH
Non-Executive Director Large shareholder
6,422 -0.6%
7.12
US$45,741 		6,422 -0.6% 7.12 US$45,741
2025-07-01 2025-07-01 S Sale
4.0
PARMAR KUSH
Non-Executive Director Large shareholder
18,578 -0.6%
7.12
US$132,324 		18,578 -0.6% 7.12 US$132,324
2025-07-01 2025-07-01 S Sale
3.5
5AM Ventures V, L.P.
Large shareholder
6,422 -0.6%
7.12
US$45,741 		6,422 -0.6% 7.12 US$45,741
2025-07-01 2025-07-01 S Sale
3.5
5AM Ventures V, L.P.
Large shareholder
18,578 -0.6%
7.12
US$132,324 		18,578 -0.6% 7.12 US$132,324
2025-07-01 2025-06-30 S Sale
4.0
PARMAR KUSH
Non-Executive Director Large shareholder
6,422 -0.6%
6.81
US$43,751 		6,422 -0.6% 6.81 US$43,751
2025-07-01 2025-06-30 S Sale
4.0
PARMAR KUSH
Non-Executive Director Large shareholder
18,578 -0.6%
6.81
US$126,566 		18,578 -0.6% 6.81 US$126,566
2025-07-01 2025-06-30 S Sale
3.5
5AM Ventures V, L.P.
Large shareholder
6,422 -0.6%
6.81
US$43,751 		6,422 -0.6% 6.81 US$43,751
2025-07-01 2025-06-30 S Sale
3.5
5AM Ventures V, L.P.
Large shareholder
18,578 -0.6%
6.81
US$126,566 		18,578 -0.6% 6.81 US$126,566
2025-07-01 2025-06-27 S Sale
4.0
PARMAR KUSH
Non-Executive Director Large shareholder
19,265 -1.7%
6.91
US$133,121 		19,265 -1.7% 6.91 US$133,121
2025-07-01 2025-06-27 S Sale
4.0
PARMAR KUSH
Non-Executive Director Large shareholder
55,735 -1.7%
6.91
US$385,129 		55,735 -1.7% 6.91 US$385,129
2025-07-01 2025-06-27 S Sale
3.5
5AM Ventures V, L.P.
Large shareholder
19,265 -1.7%
6.91
US$133,121 		19,265 -1.7% 6.91 US$133,121
2025-07-01 2025-06-27 S Sale
3.5
5AM Ventures V, L.P.
Large shareholder
55,735 -1.7%
6.91
US$385,129 		55,735 -1.7% 6.91 US$385,129
2025-06-27 2025-06-27 PrS Proposed sale
3.6
5AM Opportunities I, L.P.

Director

Non-Executive Director
19,265
6.91
US$133,121 		19,265 6.91 US$133,121
2025-06-27 2025-06-27 PrS Proposed sale
3.5
5AM Ventures V, L.P.

Director

Non-Executive Director
55,735
6.91
US$385,129 		55,735 6.91 US$385,129
2025-03-19 2025-03-17 PlS Planned sale
3.4
WENTWORTH KORY JAMES

Chief Financial Officer

Officer
1,784 -1.6%
10.67
US$19,035 		1,784 -1.6% 10.67 US$19,035
2025-03-17 2025-03-17 PrS Proposed sale
3.4
KORY WENTWORTH

Officer

Officer
1,784
10.81
US$19,285 		1,784 10.81 US$19,285
2024-12-12 2024-12-11 S Sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
21,787 -0.5%
20.23
US$440,751 		21,787 -0.5% 20.23 US$440,751
2024-12-12 2024-12-11 S Sale
3.3
MPM BIOVENTURES 2018, L.P.
Large shareholder
21,787 -0.5%
20.23
US$440,751 		21,787 -0.5% 20.23 US$440,751
2024-12-12 2024-12-10 S Sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
22,935 -0.5%
20.77
US$476,360 		22,935 -0.5% 20.77 US$476,360
Explore more

More insider trading research around Entrada Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America